肿瘤学
首页 / 立博客户端app下载的治疗领域 /肿瘤学
立博客户端app下载有一个大胆的抱负，为各种形式的癌症提供治疗方法. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save the lives of people around the world.
立博客户端app下载的主要疾病领域
立博客户端app下载的重点是一些最具敌意和最难治疗的癌症. By understanding the complexities of cancer, we hope to achieve life-changing benefits for patients.
肺癌
立博客户端app下载处于 肺癌 治疗的前沿. Learn how we are prioritising precision medicine to deliver medicines matched to the patients who can best benefit from them in early stages – where we aim to help patients live longer and cancer-free – to late stages, 立博客户端app下载希望有意义地延长生存时间.
乳腺癌
We have a long history in breast cancer and have always followed the science in providing innovative treatments. 乳腺癌的分类方法在不断发展, 了解更多关于 立博客户端app下载如何重新定义未来治疗乳腺癌 的信息.
卵巢癌
立博客户端app下载正在加强对卵巢癌的承诺. Read more on our approach to using ground-breaking science to further our understanding of the many biomarkers involved in ovarian cancer and how new therapies can be used to target these and improve outcomes.
血癌
立博客户端app下载正在推动科学的界限，重新定义血液学的护理. 阅读更多关于立博客户端app下载解决血癌的方法, 多种多样和复杂的疾病家族, 以及立博客户端app下载对医疗保健产生重大影响的承诺, 由病人的见解塑造.
前列腺癌
__1617885516_92.191.103.201.jpg/jcr:content/renditions/cq5dam.web.1200.CP_Prostate square (1)__1617885516_92.191.103.201.jpg)
立博客户端app下载有 个体化治疗前列腺癌的方法. Learn more about the role that genetics and biomarkers can play in this disease and how our personalised approach is combatting these features of prostate cancer.
肝癌
We are exploring novel immunotherapy combinations for overcoming the drivers of immunosuppression involved in liver cancer. Read more about our ambition to improve survival for these patients who are in urgent need of new effective treatments.
胰腺癌
立博客户端app下载正在引领胰腺癌的革命. Learn more about this hard to detect cancer and how our ongoing research into the biomarkers involved has given rise to improved understanding and targeted therapies.
在聚光灯下
焦点:新常态，同样的癌症
阅读更多关于新常态，同样的癌症
In 2020, 立博客户端app下载与世界各地的全球患者联盟合作，推出了“新常态”, 相同的癌症. This programme raises awareness of the impact of the COVID-19 pandemic on cancer care and calls for those experiencing new symptoms or are waiting to attend routine screening appointments not to wait any longer to contact their doctor.
焦点:Lung Ambition Alliance
阅读更多关于肺野心联盟的信息
肺癌是立博平台研发的重点. Our expanding portfolio aims to provide medicines that can improve outcomes at every stage of the disease. But we know if we are to make meaningful progress for lung cancer patients, we cannot work alone. We have partnered with the International Association for the Study of Lung Cancer (IASLC), 全球肺癌联盟(GLCC), 和Guardant Health组成Lung Ambition联盟. Together we are taking urgent action to double five-year survival in lung cancer globally by 2025 – prioritising research and projects that increase screening, 提供创新药物，提高护理质量.
认识立博客户端app下载的团队
加入立博平台
帮助立博客户端app下载重新定义癌症治疗
Be among colleagues who are driven by our passion, our people and a culture of innovation. 立博客户端app下载重视勇气、好奇心、合作精神和学习热情. We encourage disruptive thinking where failure is an opportunity to learn – having the freedom to take risks without fear of failure.
立博客户端app下载的资源
共享临床试验信息
We publish information about the registration and results of all new and ongoing clinical trials for all products in all phases on our dedicated website.
关于立博客户端app下载药品的信息
立博客户端app下载的药品在个别国家获得了特定用途的批准. 访问您当地的立博平台网站以了解更多信息.